Founded
KANDO id: 283557

Corporate information

Registration country

Company type

A biotechnology company, develops medicines to treat cancer and fibrotic diseases

Funding rounds

Acquisition USD 225,000,000


USD 225,000,000 ( ) at USD 225,000,000 pre-money valuation

Profile Country Notes
Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. USD 225,000,000 (USD 225,000,000)

Profile Country
Duff Ackerman & Goodrich Ventures (DAG Ventures) A mid-stage venture capital partnership with a service-oriented mindset.
Healthcare Ventures LLC Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage.
Kleiner Perkins Caufield & Byers LLC (KPCB) Venture capital firm.
Northgate Capital


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials